Table 1.
Clinical and demographic data in 42 asymptomatic SARS‐CoV‐2‐positive pregnant women and their neonates
| Case | Maternal age (years) | Developed symptoms after discharge | Maternal comorbidity/pregnancy complication | Neonatal sex | Birth weight (g) | Birth length (cm) | GA at birth (weeks) | 1‐/5‐min Apgar score | Neonatal outcome |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 25 | Yes | DM2 | F | 2815 | 47.5 | 38.0 | 8/9 | A&W |
| 2 | 40 | Yes | GDM | M | 3645 | 52.0 | 39.0 | 8/9 | A&W |
| 3 | 30 | Yes | Cholestasis | F | 2815 | 48.0 | 37.3 | 8/9 | NND |
| 4 | 28 | Yes | Obesity | M | 3250 | 50.0 | 38.4 | 8/9 | A&W |
| 5 | 25 | Yes | Obesity, metabolic syndrome | F | 2615 | 47.0 | 39.6 | 7/9 | Umbilical hernia, patent urachus |
| 6 | 23 | Yes | DM1, hypothyroidism | M | 3025 | 49.0 | 37.6 | 9/9 | A&W |
| 7 | 33 | Yes | None | M | 3580 | 53.0 | 38.4 | 8/9 | A&W |
| 8 | 27 | Yes | None | M | 3010 | 49.0 | 38.1 | 9/9 | A&W |
| 9 | 33 | Yes | Obesity | M | 2960 | 49.0 | 38.1 | 8/9 | A&W |
| 10 | 33 | No | Rheumatoid arthritis | M | 1965 | 43.5 | 36.2 | 8/9 | Low birth weight |
| 11 | 45 | Yes | None | F | 3060 | 50.0 | 38.2 | 8/9 | A&W |
| 12 | 37 | No | None | M | 2835 | 48.0 | 37.2 | 8/9 | Ventriculomegaly |
| 13 | 23 | No | None | M | 2790 | 48.0 | 38.4 | 8/9 | A&W |
| 14 | 37 | No | None | M | 3215 | 49.0 | 39.2 | 8/9 | A&W |
| 15 | 35 | Yes | DM2, hypothyroidism | M | 3505 | 48.0 | 38.0 | 8/9 | A&W |
| 16 | 30 | Yes | None | F | 3305 | 50.0 | 38.1 | 9/9 | A&W |
| 17 | 36 | Yes | Hypothyroidism | M | 3245 | 51.0 | 38.0 | 8/9 | A&W |
| 18 | 37 | No | None | F | 2685 | 48.0 | 39.5 | 8/9 | A&W |
| 19 | 22 | No | None | M | 3020 | 51.0 | 38.6 | 8/9 | A&W |
| 20 | 24 | No | None | F | 3125 | 49.0 | 40.0 | 9/9 | A&W |
| 21 | 33 | No | PAS | F | 2730 | 48.0 | 37.2 | 7/9 | A&W |
| 22 | 43 | No | High BP, obesity | M | 3680 | 50.0 | 38.6 | 8/9 | A&W |
| 23 | 37 | Yes | PAS | F | 3790 | 45.0 | 38.0 | 8/9 | Dysmorphic syndrome |
| 24 | 28 | Yes | DM2 | F | 3225 | 51.0 | 38.4 | 8/9 | A&W |
| 25 | 24 | Yes | None | M | 3165 | 50.5 | 38.5 | 8/9 | A&W |
| 26 | 38 | No | None | M | 3090 | 50.0 | 38.4 | 8/10 | A&W |
| 27 | 32 | Yes | None | M | 3930 | 53.0 | 39.5 | 8/9 | A&W |
| 28 | 23 | Yes | Anorexia, hydronephrosis | F | 3245 | 51.0 | 39.4 | 8/9 | A&W |
| 29 | 28 | Yes | None | M | 3360 | 49.0 | 37.1 | 9/9 | Tuberous sclerosis |
| 30 | 27 | Yes | None | M | 3320 | 52.0 | 37.1 | 8/9 | A&W |
| 31 | 22 | Yes | HIV | F | 3005 | 49.0 | 39.0 | 8/9 | A&W |
| 32 | 24 | No | None | M | 2710 | 49.5 | 40.5 | 8/9 | A&W |
| 33 | 35 | Yes | None | F | 2745 | 46.0 | 38.5 | 8/9 | Complex CHD, NND |
| 34 | 35 | No | Obesity | F | 3525 | 52.5 | 39.4 | 8/9 | A&W |
| 35 | 25 | No | GDM | M | 2985 | 51.0 | 37.6 | 9/9 | A&W |
| 36 | 35 | No | None | M | 2765 | 49.0 | 38.1 | 8/9 | A&W |
| 37 | 33 | No | None | F | 2970 | 49.5 | 39.6 | 8/9 | A&W |
| 38 | 36 | Yes | HIV | M | 3170 | 49.0 | 39.0 | 8/9 | A&W |
| 39 | 37 | Yes | DM2, hypothyroidism, high BP | M | 3690 | 52.0 | 38.3 | 8/9 | A&W |
| 40 | 24 | No | None | M | 2980 | 49.0 | 40.1 | 8/9 | A&W |
| 41 | 29 | No | None | M | 2535 | 48.0 | 40.2 | 8/9 | HLHS, chromosomal abnormality, NND |
| 42 | 26 | Yes | Pyelonephritis, pyelectasis | F | 2905 | 50.0 | 39.5 | 8/9 | A&W |
| Mean ± SD | 30.88 ± 6.09 | — | — | — | 3094.88 ± 382.08 | 49.38 ± 1.99 | 38.52 ± 0.95 | — | — |
A&W, alive and well at discharge; BP, blood pressure; CHD, congenital heart disease; DM1, Type‐1 diabetes mellitus; DM2, Type‐2 diabetes mellitus; F, female; GA, gestational age; GDM, gestational diabetes mellitus; HIV, human immunodeficiency virus; HLHS, hypoplastic left heart syndrome; M, male; NND, neonatal death; PAS, placenta accreta spectrum disorder.